Company / Total Assets
CRESCENT BIOPHARMA, INC. Total Assets History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$240.3M
FY2025
5-year range
$42.4M / $240.3M
FY2021-FY2025
Trend
+86.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $42M to $240M over the past 9 years.
Based on SEC 10-K filings.
$240M in FY2025 with a 10-year CAGR of +17.4%.
Improved from $42M to $240M over the past 9 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +17.4%
Key checks
Key Insights
- In FY2025, total assets increased 86.9% year-over-year.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $240.3M | +86.9% |
| FY2017 | $128.6M | +203.3% |
| FY2016 | $42.4M | -12.5% |
| FY2015 | $48.5M | -15.4% |
| FY2014 | $57.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026